The market for continuous glucose monitors, such as DexCom Inc.’s G4 Platinum device, was worth about $195 million in 2012 and is expected to grow to $569 million by 2020.

The market for continuous glucose monitors, such as DexCom Inc.’s G4 Platinum device, was worth about $195 million in 2012 and is expected to grow to $569 million by 2020. Photo by DexCom Inc.

Regulators have deemed DexCom Inc’s newest blood sugar monitor safe and accurate for children, opening an underserved — and lucrative — juvenile diabetes market for a company whose stock and revenue have already been ablaze this year...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99